Research
Influence of retirement on nonadherence to medication for hypertension and diabetes
Mika Kivimäki, G. David Batty, Mark Hamer, Hermann Nabi, Maarit Korhonen, Risto Huupponen, Jaana Pentti, Tuula Oksanen, Ichiro Kawachi, Marianna Virtanen, Hugo Westerlund and Jussi Vahtera
CMAJ November 19, 2013 185 (17) E784-E790; DOI: https://doi.org/10.1503/cmaj.122010
Mika Kivimäki
Department of Epidemiology and Public Health (Kivimäki, Batty, Hamer), University College London, London, UK; Finnish Institute of Occupational Health and University of Helsinki (Kivimäki, Pentti, Oksanen, Virtanen, Vahtera), Helsinki, Finland; Centre for Cognitive Aging and Cognitive Epidemiology (Batty), University of Edinburgh, Edinburgh, UK; Institut national de la santé et de la recherche médicale (Nabi), Centre for Research in Epidemiology and Population Health, Villejuif, France; Department of Pharmacology (Korhonen, Huupponen), Drug Development and Therapeutics, University of Turku, and Turku University Hospital, Turku, Finland; Harvard School of Public Health (Kawachi), Boston, Mass.; Stress Research Institute (Westerlund), Stockholm University, Stockholm, Sweden; Department of Public Health (Vahtera), University of Turku, and Turku University Hospital, Turku, Finland
PhDG. David Batty
Department of Epidemiology and Public Health (Kivimäki, Batty, Hamer), University College London, London, UK; Finnish Institute of Occupational Health and University of Helsinki (Kivimäki, Pentti, Oksanen, Virtanen, Vahtera), Helsinki, Finland; Centre for Cognitive Aging and Cognitive Epidemiology (Batty), University of Edinburgh, Edinburgh, UK; Institut national de la santé et de la recherche médicale (Nabi), Centre for Research in Epidemiology and Population Health, Villejuif, France; Department of Pharmacology (Korhonen, Huupponen), Drug Development and Therapeutics, University of Turku, and Turku University Hospital, Turku, Finland; Harvard School of Public Health (Kawachi), Boston, Mass.; Stress Research Institute (Westerlund), Stockholm University, Stockholm, Sweden; Department of Public Health (Vahtera), University of Turku, and Turku University Hospital, Turku, Finland
PhDMark Hamer
Department of Epidemiology and Public Health (Kivimäki, Batty, Hamer), University College London, London, UK; Finnish Institute of Occupational Health and University of Helsinki (Kivimäki, Pentti, Oksanen, Virtanen, Vahtera), Helsinki, Finland; Centre for Cognitive Aging and Cognitive Epidemiology (Batty), University of Edinburgh, Edinburgh, UK; Institut national de la santé et de la recherche médicale (Nabi), Centre for Research in Epidemiology and Population Health, Villejuif, France; Department of Pharmacology (Korhonen, Huupponen), Drug Development and Therapeutics, University of Turku, and Turku University Hospital, Turku, Finland; Harvard School of Public Health (Kawachi), Boston, Mass.; Stress Research Institute (Westerlund), Stockholm University, Stockholm, Sweden; Department of Public Health (Vahtera), University of Turku, and Turku University Hospital, Turku, Finland
PhDHermann Nabi
Department of Epidemiology and Public Health (Kivimäki, Batty, Hamer), University College London, London, UK; Finnish Institute of Occupational Health and University of Helsinki (Kivimäki, Pentti, Oksanen, Virtanen, Vahtera), Helsinki, Finland; Centre for Cognitive Aging and Cognitive Epidemiology (Batty), University of Edinburgh, Edinburgh, UK; Institut national de la santé et de la recherche médicale (Nabi), Centre for Research in Epidemiology and Population Health, Villejuif, France; Department of Pharmacology (Korhonen, Huupponen), Drug Development and Therapeutics, University of Turku, and Turku University Hospital, Turku, Finland; Harvard School of Public Health (Kawachi), Boston, Mass.; Stress Research Institute (Westerlund), Stockholm University, Stockholm, Sweden; Department of Public Health (Vahtera), University of Turku, and Turku University Hospital, Turku, Finland
PhDMaarit Korhonen
Department of Epidemiology and Public Health (Kivimäki, Batty, Hamer), University College London, London, UK; Finnish Institute of Occupational Health and University of Helsinki (Kivimäki, Pentti, Oksanen, Virtanen, Vahtera), Helsinki, Finland; Centre for Cognitive Aging and Cognitive Epidemiology (Batty), University of Edinburgh, Edinburgh, UK; Institut national de la santé et de la recherche médicale (Nabi), Centre for Research in Epidemiology and Population Health, Villejuif, France; Department of Pharmacology (Korhonen, Huupponen), Drug Development and Therapeutics, University of Turku, and Turku University Hospital, Turku, Finland; Harvard School of Public Health (Kawachi), Boston, Mass.; Stress Research Institute (Westerlund), Stockholm University, Stockholm, Sweden; Department of Public Health (Vahtera), University of Turku, and Turku University Hospital, Turku, Finland
PhDRisto Huupponen
Department of Epidemiology and Public Health (Kivimäki, Batty, Hamer), University College London, London, UK; Finnish Institute of Occupational Health and University of Helsinki (Kivimäki, Pentti, Oksanen, Virtanen, Vahtera), Helsinki, Finland; Centre for Cognitive Aging and Cognitive Epidemiology (Batty), University of Edinburgh, Edinburgh, UK; Institut national de la santé et de la recherche médicale (Nabi), Centre for Research in Epidemiology and Population Health, Villejuif, France; Department of Pharmacology (Korhonen, Huupponen), Drug Development and Therapeutics, University of Turku, and Turku University Hospital, Turku, Finland; Harvard School of Public Health (Kawachi), Boston, Mass.; Stress Research Institute (Westerlund), Stockholm University, Stockholm, Sweden; Department of Public Health (Vahtera), University of Turku, and Turku University Hospital, Turku, Finland
PhDJaana Pentti
Department of Epidemiology and Public Health (Kivimäki, Batty, Hamer), University College London, London, UK; Finnish Institute of Occupational Health and University of Helsinki (Kivimäki, Pentti, Oksanen, Virtanen, Vahtera), Helsinki, Finland; Centre for Cognitive Aging and Cognitive Epidemiology (Batty), University of Edinburgh, Edinburgh, UK; Institut national de la santé et de la recherche médicale (Nabi), Centre for Research in Epidemiology and Population Health, Villejuif, France; Department of Pharmacology (Korhonen, Huupponen), Drug Development and Therapeutics, University of Turku, and Turku University Hospital, Turku, Finland; Harvard School of Public Health (Kawachi), Boston, Mass.; Stress Research Institute (Westerlund), Stockholm University, Stockholm, Sweden; Department of Public Health (Vahtera), University of Turku, and Turku University Hospital, Turku, Finland
MScTuula Oksanen
Department of Epidemiology and Public Health (Kivimäki, Batty, Hamer), University College London, London, UK; Finnish Institute of Occupational Health and University of Helsinki (Kivimäki, Pentti, Oksanen, Virtanen, Vahtera), Helsinki, Finland; Centre for Cognitive Aging and Cognitive Epidemiology (Batty), University of Edinburgh, Edinburgh, UK; Institut national de la santé et de la recherche médicale (Nabi), Centre for Research in Epidemiology and Population Health, Villejuif, France; Department of Pharmacology (Korhonen, Huupponen), Drug Development and Therapeutics, University of Turku, and Turku University Hospital, Turku, Finland; Harvard School of Public Health (Kawachi), Boston, Mass.; Stress Research Institute (Westerlund), Stockholm University, Stockholm, Sweden; Department of Public Health (Vahtera), University of Turku, and Turku University Hospital, Turku, Finland
PhDIchiro Kawachi
Department of Epidemiology and Public Health (Kivimäki, Batty, Hamer), University College London, London, UK; Finnish Institute of Occupational Health and University of Helsinki (Kivimäki, Pentti, Oksanen, Virtanen, Vahtera), Helsinki, Finland; Centre for Cognitive Aging and Cognitive Epidemiology (Batty), University of Edinburgh, Edinburgh, UK; Institut national de la santé et de la recherche médicale (Nabi), Centre for Research in Epidemiology and Population Health, Villejuif, France; Department of Pharmacology (Korhonen, Huupponen), Drug Development and Therapeutics, University of Turku, and Turku University Hospital, Turku, Finland; Harvard School of Public Health (Kawachi), Boston, Mass.; Stress Research Institute (Westerlund), Stockholm University, Stockholm, Sweden; Department of Public Health (Vahtera), University of Turku, and Turku University Hospital, Turku, Finland
PhDMarianna Virtanen
Department of Epidemiology and Public Health (Kivimäki, Batty, Hamer), University College London, London, UK; Finnish Institute of Occupational Health and University of Helsinki (Kivimäki, Pentti, Oksanen, Virtanen, Vahtera), Helsinki, Finland; Centre for Cognitive Aging and Cognitive Epidemiology (Batty), University of Edinburgh, Edinburgh, UK; Institut national de la santé et de la recherche médicale (Nabi), Centre for Research in Epidemiology and Population Health, Villejuif, France; Department of Pharmacology (Korhonen, Huupponen), Drug Development and Therapeutics, University of Turku, and Turku University Hospital, Turku, Finland; Harvard School of Public Health (Kawachi), Boston, Mass.; Stress Research Institute (Westerlund), Stockholm University, Stockholm, Sweden; Department of Public Health (Vahtera), University of Turku, and Turku University Hospital, Turku, Finland
PhDHugo Westerlund
Department of Epidemiology and Public Health (Kivimäki, Batty, Hamer), University College London, London, UK; Finnish Institute of Occupational Health and University of Helsinki (Kivimäki, Pentti, Oksanen, Virtanen, Vahtera), Helsinki, Finland; Centre for Cognitive Aging and Cognitive Epidemiology (Batty), University of Edinburgh, Edinburgh, UK; Institut national de la santé et de la recherche médicale (Nabi), Centre for Research in Epidemiology and Population Health, Villejuif, France; Department of Pharmacology (Korhonen, Huupponen), Drug Development and Therapeutics, University of Turku, and Turku University Hospital, Turku, Finland; Harvard School of Public Health (Kawachi), Boston, Mass.; Stress Research Institute (Westerlund), Stockholm University, Stockholm, Sweden; Department of Public Health (Vahtera), University of Turku, and Turku University Hospital, Turku, Finland
PhDJussi Vahtera
Department of Epidemiology and Public Health (Kivimäki, Batty, Hamer), University College London, London, UK; Finnish Institute of Occupational Health and University of Helsinki (Kivimäki, Pentti, Oksanen, Virtanen, Vahtera), Helsinki, Finland; Centre for Cognitive Aging and Cognitive Epidemiology (Batty), University of Edinburgh, Edinburgh, UK; Institut national de la santé et de la recherche médicale (Nabi), Centre for Research in Epidemiology and Population Health, Villejuif, France; Department of Pharmacology (Korhonen, Huupponen), Drug Development and Therapeutics, University of Turku, and Turku University Hospital, Turku, Finland; Harvard School of Public Health (Kawachi), Boston, Mass.; Stress Research Institute (Westerlund), Stockholm University, Stockholm, Sweden; Department of Public Health (Vahtera), University of Turku, and Turku University Hospital, Turku, Finland
PhDArticle Information
vol. 185 no. 17 E784-E790
PubMed
History
- Published online November 18, 2013.
Article Versions
- Latest version (September 30, 2013 - 08:20).
- Latest version (October 7, 2013 - 08:15).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2013 Canadian Medical Association or its licensors
Author Information
- Mika Kivimäki, PhD⇑,
- G. David Batty, PhD,
- Mark Hamer, PhD,
- Hermann Nabi, PhD,
- Maarit Korhonen, PhD,
- Risto Huupponen, PhD,
- Jaana Pentti, MSc,
- Tuula Oksanen, PhD,
- Ichiro Kawachi, PhD,
- Marianna Virtanen, PhD,
- Hugo Westerlund, PhD,
- Jussi Vahtera, PhD
- Department of Epidemiology and Public Health (Kivimäki, Batty, Hamer), University College London, London, UK; Finnish Institute of Occupational Health and University of Helsinki (Kivimäki, Pentti, Oksanen, Virtanen, Vahtera), Helsinki, Finland; Centre for Cognitive Aging and Cognitive Epidemiology (Batty), University of Edinburgh, Edinburgh, UK; Institut national de la santé et de la recherche médicale (Nabi), Centre for Research in Epidemiology and Population Health, Villejuif, France; Department of Pharmacology (Korhonen, Huupponen), Drug Development and Therapeutics, University of Turku, and Turku University Hospital, Turku, Finland; Harvard School of Public Health (Kawachi), Boston, Mass.; Stress Research Institute (Westerlund), Stockholm University, Stockholm, Sweden; Department of Public Health (Vahtera), University of Turku, and Turku University Hospital, Turku, Finland
- Correspondence to: Mika Kivimäki, m.kivimaki{at}ucl.ac.uk
Statistics from Altmetric.com
In this issue
Article tools
Respond to this article
Influence of retirement on nonadherence to medication for hypertension and diabetes
Mika Kivimäki, G. David Batty, Mark Hamer, Hermann Nabi, Maarit Korhonen, Risto Huupponen, Jaana Pentti, Tuula Oksanen, Ichiro Kawachi, Marianna Virtanen, Hugo Westerlund, Jussi Vahtera
CMAJ Nov 2013, 185 (17) E784-E790; DOI: 10.1503/cmaj.122010
Influence of retirement on nonadherence to medication for hypertension and diabetes
Mika Kivimäki, G. David Batty, Mark Hamer, Hermann Nabi, Maarit Korhonen, Risto Huupponen, Jaana Pentti, Tuula Oksanen, Ichiro Kawachi, Marianna Virtanen, Hugo Westerlund, Jussi Vahtera
CMAJ Nov 2013, 185 (17) E784-E790; DOI: 10.1503/cmaj.122010
Jump to section
Related Articles
Cited By...
- Adherence to treatment and its predictive factors among adults with type 2 diabetes in northern Iran
- Childhood Psychosocial Adversity and Adult Neighborhood Disadvantage as Predictors of Cardiovascular Disease: A Cohort Study
- Lifestyle factors as predictors of nonadherence to statin therapy among patients with and without cardiovascular comorbidities
- Physical Functioning in work and retirement: commentary on age-related trajectories of physical functioning in work and retirement --the role of sociodemographic factors, lifestyle and disease by Stenholm et al